Jonathan Andrew Fallowfield (J A Fallowfield, Jonathan A Fallowfield)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 25

Top Venues

Journal of clinical medicine

Alimentary pharmacology & therapeutics

Expert opinion on emerging drugs

Liver international : official journal of the International Association for the Study of the Liver

This page only lists publications with an associated author ORCID identifier.

Publications

Timothy J Kendall, Elaine Chng, Yayun Ren, Dean Tai, Gideon Ho, Jonathan Andrew Fallowfield
Outcome prediction in metabolic dysfunction-associated steatotic liver disease using stain-free digital pathological assessment. Liver international : official journal of the International Association for the Study of the Liver (2024)
Jonathan Andrew Fallowfield, Maria Jimenez Ramos
Emerging synthetic drugs for the treatment of hepatic cirrhosis: a 2024 update. Expert opinion on emerging drugs (2024)
Jonathan Andrew Fallowfield, Maria Jimenez Ramos
Emerging synthetic drugs for the treatment of hepatic cirrhosis: a 2024 update. Expert opinion on emerging drugs (2024)
Katie Morgan, Steven D Morley, Arslan Khaliq Raja, Martin Vandeputte, Kay Samuel, Martin Waterfall, Natalie Z M Homer, Peter C Hayes, Jonathan Andrew Fallowfield, John N Plevris
Metabolism of Acetaminophen by Enteric Epithelial Cells Mitigates Hepatocellular Toxicity In Vitro. Journal of clinical medicine 12 (12) (2023)
Paul Noel Brennan, Ahmed M Elsharkawy, Timothy James Kendall, Rohit Loomba, Derek A Mann, Jonathan Andrew Fallowfield
Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach. Nature reviews. Gastroenterology & hepatology (2023)
Timothy James Kendall, Maria Jimenez-Ramos, Frances Turner, Prakash Ramachandran, Jessica Minnier, Michael D McColgan, Masood Alam, Harriet Ellis, Donald R Dunbar, Gabriele Kohnen, Prakash Konanahalli, Karin A Oien, Lucia Bandiera, Filippo Menolascina, Anna Juncker-Jensen, Douglas Alexander, Charlie Mayor, Indra Neil Guha, Jonathan Andrew Fallowfield
An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease. Nature medicine (2023)
Katie Morgan, Steven D Morley, Arslan Khaliq Raja, Martin Vandeputte, Kay Samuel, Martin Waterfall, Natalie Z M Homer, Peter C Hayes, Jonathan Andrew Fallowfield, John N Plevris
Metabolism of Acetaminophen by Enteric Epithelial Cells Mitigates Hepatocellular Toxicity In Vitro. Journal of clinical medicine 12 (12) (2023)
Jonathan Andrew Fallowfield, Maria Jimenez-Ramos, Andrew Robertson
Emerging synthetic drugs for the treatment of liver cirrhosis. Expert opinion on emerging drugs 26 (2) (2021)
Cameron J Fairfield, Thomas M Drake, Riinu Pius, Andrew D Bretherick, Archie Campbell, David W Clark, Jonathan Andrew Fallowfield, Caroline Hayward, Neil Cowan Henderson, Andrii Iakovliev, Peter K Joshi, Nicholas L Mills, David J Porteous, Prakash Ramachandran, Robert K Semple, Catherine A Shaw, Cathie L W Sudlow, Paul R H J Timmers, James F Wilson, Stephen J Wigmore, Athina Spiliopoulou, Ewen M Harrison
Genome-wide analysis identifies gallstone-susceptibility loci including genes regulating gastrointestinal motility. Hepatology (Baltimore, Md.) (2021)
Naaventhan Palaniyappan, Jonathan Andrew Fallowfield
Editorial: metformin for portal hypertension-old dog, new tricks? Alimentary pharmacology & therapeutics 54 (3) (2021)
Cameron J Fairfield, Thomas M Drake, Riinu Pius, Andrew D Bretherick, Archie Campbell, David W Clark, Jonathan Andrew Fallowfield, Caroline Hayward, Neil Cowan Henderson, Peter K Joshi, Nicholas L Mills, David J Porteous, Prakash Ramachandran, Robert K Semple, Catherine A Shaw, Cathie L M Sudlow, Paul R H J Timmers, James F Wilson, Stephen J Wigmore, Ewen M Harrison, Athina Spiliopoulou
Genome-Wide Association Study of NAFLD Using Electronic Health Records. Hepatology communications (2021)
Jonathan Andrew Fallowfield, Prakash Ramachandran
A relaxin-based nanotherapy for liver fibrosis. Nature nanotechnology 16 (4) (2021)
Sheila M Grecian, Stela McLachlan, Jonathan Andrew Fallowfield, Patrick K A Kearns, Peter C Hayes, Neil I Guha, Joanne R Morling, Stephen Glancy, Rachel M Williamson, Rebecca M Reynolds, Brian M Frier, Nicola N Zammitt, Jackie F Price, Mark W J Strachan
Non-invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh type 2 diabetes study. Liver international : official journal of the International Association for the Study of the Liver 40 (9) (2020)
Fiona J Gifford, Philip D J Dunne, Graeme Weir, Hamish Ireland, Catriona Graham, Sharon Tuck, Peter C Hayes, Jonathan Andrew Fallowfield
A phase 2 randomised controlled trial of serelaxin to lower portal pressure in cirrhosis (STOPP). Trials 21 (1) (2020)
Xiaolong Qi, Yanna Liu, Jitao Wang, Jonathan Andrew Fallowfield, Jianwen Wang, Xinyu Li, Jindong Shi, Hongqiu Pan, Shengqiang Zou, Hongguang Zhang, Zhenhuai Chen, Fujian Li, Yan Luo, Mei Mei, Huiling Liu, Zhengyan Wang, Jinlin Li, Hua Yang, Huihua Xiang, Xiaodan Li, Tao Liu, Ming-Hua Zheng, Chuan Liu, Yifei Huang, Dan Xu, Xiaoguo Li, Ning Kang, Qing He, Ye Gu, Guo Zhang, Chuxiao Shao, Dengxiang Liu, Lin Zhang, Xun Li, Norifumi Kawada, Zicheng Jiang, Fengmei Wang, Bin Xiong, Tetsuo Takehara, Don C Rockey, null null
Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study. Gut 70 (2) (2020)
Damian J Mole, Jonathan Andrew Fallowfield, Ahmed E Sherif, Timothy Kendall, Scott Semple, Matt Kelly, Gerard Ridgway, John J Connell, John McGonigle, Rajarshi Banerjee, J Michael Brady, Xiaozhong Zheng, Michael Hughes, Lucile Neyton, Joanne McClintock, Garry Tucker, Hilary Nailon, Dilip Patel, Anthony Wackett, Michelle Steven, Fenella Welsh, Myrddin Rees, null null
Quantitative magnetic resonance imaging predicts individual future liver performance after liver resection for cancer. PloS one 15 (12) (2020)
Fiona J Gifford, Francesca Moroni, Tariq E Farrah, Kirstie Hetherington, Thomas J MacGillivray, Peter C Hayes, Neeraj Dhaun, Jonathan Andrew Fallowfield
The Eye as a Non-Invasive Window to the Microcirculation in Liver Cirrhosis: A Prospective Pilot Study. Journal of clinical medicine 9 (10) (2020)
Francesca Moroni, Benjamin J Dwyer, Catriona Graham, Chloe Pass, Laura Bailey, Lisa Ritchie, Donna Mitchell, Alison Glover, Audrey Laurie, Stuart Doig, Emily Hargreaves, Alasdair R Fraser, Marc L Turner, John D M Campbell, Neil W A McGowan, Jacqueline Barry, Joanna K Moore, Peter C Hayes, Diana J Leeming, Mette J Nielsen, Kishwar Musa, Jonathan Andrew Fallowfield, Stuart John Forbes
Safety profile of autologous macrophage therapy for liver cirrhosis. Nature medicine 25 (10) (2019)
P D J Dunne, Jonathan Andrew Fallowfield
Editorial: getting bullish about portal hypertension-chronic treatment with oral taurine? Alimentary pharmacology & therapeutics 47 (4) (2019)
Natasha McDonald, Peter J Eddowes, James Hodson, Scott I K Semple, Nigel P Davies, Catherine J Kelly, Stella Kin, Miranda Phillips, Amy H Herlihy, Timothy James Kendall, Rachel M Brown, Desley A H Neil, Stefan G Hübscher, Gideon M Hirschfield, Jonathan Andrew Fallowfield
Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study. Scientific reports 8 (1) (2018)
Anna M Hoy, Natasha McDonald, Ross J Lennen, Matteo Milanesi, Amy H Herlihy, Timothy J Kendall, William Mungall, Michael Gyngell, Rajarshi Banerjee, Robert L Janiczek, Philip S Murphy, Maurits A Jansen, Jonathan Andrew Fallowfield
Non-invasive assessment of liver disease in rats using multiparametric magnetic resonance imaging: a feasibility study. Biology open 7 (7) (2018)
Andrew McBride, Anna M Hoy, Mark J Bamford, Danuta E Mossakowska, Martin P Ruediger, Jeremy Griggs, Sapna Desai, Kate Simpson, Ivan Caballero-Hernandez, John P Iredale, Theresa Pell, Rebecca L Aucott, Duncan S Holmes, Scott P Webster, Jonathan Andrew Fallowfield
In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosis. Scientific reports 7 (1) (2017)
Natasha McDonald, David M L Lilburn, Neil J Lachlan, Gillian Macnaught, Dilip Patel, Arjun N A Jayaswal, Peter C Hayes, Scott I Semple, Jonathan Andrew Fallowfield
Assessment of Haemodynamic Response to Nonselective Beta-Blockers in Portal Hypertension by Phase-Contrast Magnetic Resonance Angiography. BioMed research international 2017 (2017)
Peter J Eddowes, N McDonald, N Davies, S I K Semple, T J Kendall, J Hodson, Philip Noel Newsome, R B Flintham, R Wesolowski, L Blake, R V Duarte, C J Kelly, A H Herlihy, M D Kelly, S P Olliff, S G Hübscher, Jonathan Andrew Fallowfield, Gideon M Hirschfield
Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease. Alimentary pharmacology & therapeutics 47 (5) (2017)
Victoria K Snowdon, Neil J Lachlan, Anna M Hoy, Patrick W F Hadoke, Scott I Semple, Dilip Patel, Will Mungall, Timothy James Kendall, Adrian Thomson, Ross J Lennen, Maurits A Jansen, Carmel M Moran, Antonella Pellicoro, Prakash Ramachandran, Isaac W Shaw, Rebecca L Aucott, Thomas Severin, Rajnish Saini, Judy Pak, Denise Yates, Neelesh Dongre, Jeremy S Duffield, David J Webb, John P Iredale, Peter C Hayes, Jonathan Andrew Fallowfield
Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial. PLoS medicine 14 (2) (2017)

Jonathan Andrew Fallowfield.css-eqlu8i{font-size:small;padding-left:4px;} (J A Fallowfield, Jonathan A Fallowfield)

Publication Activity (10 Years)

Top Topics

Top Venues

Jonathan Andrew Fallowfield (J A Fallowfield, Jonathan A Fallowfield)